Skip to main content

Table 2 Best tumor response and overall response rate (ORR) by disease site (n = 29)

From: Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Best tumor response

No.

%

Complete response

2

6.9

Partial response

14

48.3

Overall response rate

16

55.2 (CI 37.5–62.5)

No change

10

34.5

Progressive disease

3

10.3

ORR by disease site

  

   Breast (locally advanced)

9/12

75.0

   Viscera

9/13

69.2

   Liver

3/11

27.3

   Lymph node

6/6

100

  1. ORR, overall response rate